You are here: Welcome to the MPKB » Welcome to the MPKB » Health, food and drink » Aiming at Health » Health Maintenance and Olmesartan
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:food:aim_health:aging [02.11.2019] – [with additional studies] sallieqhome:food:aim_health:aging [02.11.2019] – [with additional studies] sallieq
Line 8: Line 8:
 ===== with additional studies ===== ===== with additional studies =====
  
- Although uncontrolled confounding might still exist, olmesartan does not seem to increase cardiovascular risk compared with losartan. (({{pubmed>long:24516110}})) + Although uncontrolled confounding might still exist, (//this was a short term study//) olmesartan does not seem to increase cardiovascular risk compared with losartan. (({{pubmed>long:24516110}})) 
  
  The ROADMAP study will answer the question whether an ARB can prevent or delay the onset of microalbuminuria and whether this translates into protection against cardiovascular events and renal disease. (({{pubmed>long:16508590}}))   The ROADMAP study will answer the question whether an ARB can prevent or delay the onset of microalbuminuria and whether this translates into protection against cardiovascular events and renal disease. (({{pubmed>long:16508590}})) 
home/food/aim_health/aging.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.